New research, market insights and care programs are changing diabetes care every day. From cutting-edge AI tools to oral treatments and community camps for kids, today’s advances matter to you as a patient or caregiver. We’ll explain each development and show you how to turn unused diabetic supplies into cash.
Market Trends: Neuropathy and Retinopathy
A recent market report, covering 2025–2032, forecasts steady growth in treatments for diabetic neuropathy. Industry giants like Eli Lilly and GlaxoSmithKline are leading the way (openpr.com).
Key takeaways:
- Rising diabetes rates worldwide drive demand for neuropathy therapies.
- New drugs and devices promise better pain relief and nerve health.
- Advanced diabetic supplies, like nerve-stimulating devices, will see wider adoption.
In parallel, the diabetic retinopathy market is set for a major shake-up by 2032. Novartis, Bayer and Regeneron are investing in AI and ML to improve early detection and personalize treatments (openpr.com).
- AI algorithms can spot sight-threatening changes sooner.
- Gene therapy and stem cell research may offer long-term solutions.
- Personalized medicine tailors injections and eye drops by patient risk.
New Care Programs for Adults and Children
The Kind Clinic in California has launched a diabetes care program for adults in partnership with Legacy Health Endowment (turlockjournal.com).
- Three physician assistants provide primary care and education.
- Medications cost just $2 each to ensure affordability.
- First 50 enrollees get extra support tools and coaching.
For younger patients, the Bahamas Diabetes Association teamed with PAHO/WHO to host a Kids with Diabetes Summer Camp (paho.org).
- 50 children learned blood glucose monitoring and fun fitness games.
- Emotional support sessions helped families connect.
- Follow-up health education strengthens at-home care.
Innovative Treatments and Medications
Beyond standard insulin therapy, new drug options are emerging:
Ceftaroline Fosamil for Osteomyelitis
A 62-year-old diabetic patient with refractory MSSA osteomyelitis improved after six weeks of ceftaroline fosamil treatment, according to a case report (cureus.com).
This antibiotic added to the treatment arsenal for bone infections in diabetics when other drugs fail.
Non-Insulin Drugs & Microvascular Benefits
A meta-analysis of randomized trials reviewed how non-insulin anti-diabetic drugs affect small vessel complications (bmcendocrdisord.biomedcentral.com). Key points:
- Thiazolidinediones, SGLT2 inhibitors and GLP-1 agonists like semaglutide may protect kidneys and eyes.
- DPP-4 inhibitors could lower neuropathy risk.
- Some GLP-1 drugs carry a higher retinopathy risk and need careful monitoring.
Oral Treatment for Diabetic Macular Edema
Boehringer Ingelheim’s BI 1815368 enters phase 2 trials for oral macular edema therapy, potentially replacing injections (healio.com).
- Targets blood vessel permeability in both eyes systemically.
- Might boost early treatment and adherence.
- Less risk of eye-infection versus injections.
Sitagliptin and Retinal Barrier Protection
A lab study found sitagliptin, a DPP-4 inhibitor, prevented blood-retinal barrier leakage in high-glucose conditions (nature.com).
Targeting p66Shc for Diabetic Nephropathy
In rats, inhibiting p66Shc restored kidney microvascular function, offering a new path to tackle diabetic nephropathy (frontiersin.org).
Nomogram for Nephropathy Progression
A risk model using clinical and biopsy data predicts kidney disease progression in type 2 diabetes, with strong accuracy up to four years (frontiersin.org).
Tech and AI in Diabetes Care
Artificial intelligence is streamlining diagnosis and research.
AI-Driven Retinopathy Classification
A self-paced, multi-scale deep learning model achieved a 0.9907 AUC in four-class diabetic retinopathy diagnosis on public datasets (nature.com).
Tear Proteomics for Keratopathy Biomarkers
Quantitative analysis of tears identified proteins linked to diabetic keratopathy, suggesting new biomarkers like VDAC3 (nature.com).
ADA Trial Recap: Personalized Type 2 Therapy
The American Diabetes Association’s Diabetes Dialogue trial found combination treatments, including metformin plus GLP-1 agonists, gave better glycemic control than single drugs (hcplive.com).
Lifestyle Insights and Social Factors
Not just medicine: social and lifestyle elements play a role.
Calorie and Time-Restricted Feeding in Rats
In type 1 diabetic rats, combining calorie restriction with time-restricted feeding preserved liver and kidney tissue and improved glycemic response (frontiersin.org).
Type 2 Diabetes, Obesity and Teen Bone Health
Obese teens with type 2 diabetes had less bone strength gains, raising lifelong fracture risk (pharmacytimes.com).
Neighborhood Deprivation and Diabetes Risk
A Swedish cohort of over one million asthma patients showed a 44% higher type 2 diabetes risk in deprived neighborhoods (nature.com).
Debunking Myths and Managing Risks
False beliefs can harm care. The University of Rochester Medical Center debunks myths about type 1 and type 2 diabetes, from sugar causation to blindness inevitability (urmc.rochester.edu).
Ozempic Side Effects and Lawsuits
GLP-1 drugs like Ozempic have warnings for vision loss, gastroparesis and intestinal blockage. Over 1,900 lawsuits in Pennsylvania federal court allege serious gastrointestinal injuries (drugwatch.com).
Enhancing Your Diabetes Experience in Retail
Pharmacies and suppliers can boost patient confidence. A recent article explains how in-store education, clear signage and lifestyle newsletters help customers manage diabetes better and improve product adherence (drugstorenews.com).
Sell Unused Supplies for Cash
Still have boxes of test strips, lancets or insulin pumps gathering dust? Turn them into cash with DiabeticSupplies.Online. We buy unused diabetic supplies for top dollar via mail order. Fast payouts and free shipping labels make it simple.
- sell my diabetic supplies online
- cash for diabetic supplies near me
- diabetic test strips buyer
- mail order diabetic supplies
Contact us today and get paid for your unused diabetic supplies.
FAQ – People Also Ask
How do I sell my unused diabetic test strips for cash?
Find a trusted buyer like DiabeticSupplies.Online. Pack your sealed, unexpired strips and mail them in. You get fast payment by check or PayPal.
Are online diabetic supply buyers safe?
Yes, if they offer clear terms, free shipping labels and verified reviews. Always confirm they are HIPAA-compliant and ship via tracked mail.
Can I sell expired diabetic supplies?
Some buyers accept recently expired test strips at reduced rates, but insulin pumps and continuous glucose monitors should be in date for safety.
What types of diabetic supplies do you buy?
We buy test strips, lancets, CGMs, insulin pens, pumps, sensors and more—unopened and unexpired only.
How soon will I receive payment?
Most sellers receive payment within 3–5 business days after we inspect your supplies.